Vaginal Gel

Known as: Vaginal Gel Dose Form, VaginalGel, Vaginal Gel Dosage Form 
A gel composed of active and/or inert ingredient(s), intended for administration in or around the vagina.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1942-2017
0102019422016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BACKGROUND Oral and vaginal preparations of tenofovir as pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV… (More)
  • table 1
  • table 3
  • table 4
  • table 5
  • table 6
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Innovative prevention strategies for HIV-1 transmission are urgently needed. PRO2000 vaginal gel was efficacious… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
UNLABELLED To assess the pharmacokinetics of dapivirine in plasma and dapivirine concentrations in cervicovaginal fluids (CVF… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND This trial evaluated the safety and effectiveness of 6% cellulose sulfate vaginal gel in preventing male-to-female… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE Preterm birth is the leading cause of perinatal morbidity and mortality worldwide. Treatment of preterm labor with… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVES To establish the highest practical dose and frequency (HPDF) of 0.3% or 1% tenofovir vaginal gel applied once or twice… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVE Efficacy study of suppressive vaginal metronidazole in reducing recurrent symptomatic episodes of bacterial vaginosis… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Bacterial vaginosis (BV) is particularly common in black women, and in Nigeria it is often caused by Mycoplasma, as well as… (More)
Is this relevant?
1995
1995
BACKGROUND Treatment options for bacterial vaginosis are numerous. The purpose of this study was to compare the efficacy of oral… (More)
Is this relevant?